Article
Epoxidase inhibitor-aspirin resistance and the relationship with genetic polymorphisms: a review
1 Feb 2024
Abstract excerpt
Strokes are the leading cause of death in most regions of the world. Epoxidase inhibitors include the drug aspirin (acetylsalicylic acid). Aspirin is widely used as first-line treatment for the prevention of cardiovascular and cerebrovascular diseases in at-risk patients. However, patients using conventional doses of aspirin can still develop ischaemic cardiovascular and cerebrovascular diseases, a phenomenon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
